Alebund Pharmaceuticals

9637 · HKEX

Public Market Listing

9637HKEX

HKEX primary exchange listing

Live quotes, historical charts, and market capitalization for Alebund Pharmaceuticals are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)
1Total Assets
0Approved
1Phase 3 / Filed
0Phase 1–2 / Early
2Diseases
Quick filter:
Showing 1 of 1 assets
Target & Modality
Phase 3
Iron-based intestinal phosphate binderSmall molecule
Chronic Kidney DiseaseHyperphosphatemia

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Regulatory and conference events

(1)

Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.

Recent

7 August 2026Filing acceptedAP301 (fiber-iron phosphate binder)China NDA accepted for review
CN, NMPA · Alebund Pharmaceuticals · Source ↗

Financial reports

Annual history (2 years)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2025-FY$4.3M$52M—$105Mreport ↗
View 1 more year
PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2024-FY$0.9M$33M—$47Mreport ↗